Bert Vogelstein awarded Warren Triennial Prize by assachusetts General Hospital

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

BERT VOGELSTEIN was awarded the 2014 Warren Triennial Prize by Massachusetts General Hospital.

Vogelstein is the Clayton Professor of Oncology and Pathology and director of the Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins University School of Medicine. The award will be presented at the Warren Triennial Prize Symposium, “The Genetics of Cancer,” on Nov. 24 at MGH.

Vogelstein and his colleagues demonstrated that colorectal tumors result from the gradual accumulation of alterations in specific oncogenes and tumor suppressor genes, with major implications for improved diagnostic and therapeutic strategies.

He and his colleagues were also the first to map cancer genomes and to use genome-wide sequencing to identify the basis of a hereditary disease. His team has determined the genetic landscapes of more than a dozen tumor types.

The Warren Prize is the top scientific award presented by MGH, and includes a cash award of $50,000. Created in 1871, the prize was named for John Collins Warren, a co-founder of the MGH who played a leading role in establishing what became the New England Journal of Medicine, and also performed the first public surgical operation utilizing ether anesthesia in 1846.

Twenty-three Warren recipients have also received the Nobel Prize–including 2011 recipient Shinya Yamanaka, a 2012 Nobel laureate; and 2004 recipients Craig Mello and Andrew Fire, who received the 2006 Nobel.

YOU MAY BE INTERESTED IN

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers. 

In the first meeting of the National Cancer Advisory Board since the inauguration of President Donald Trump, NCI Principal Deputy Director Douglas R. Lowy addressed many of the burning questions the oncology field has for the institute. On indirect costs: NCI will continue to use previously negotiated and approved indirect cost rates, with the exception...

The Cancer Letter staff were finalists for nine 2025 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists—seven for journalism; two for design—and won first place for four. The Cancer Letter’s entries recognized by SPJ include investigative journalism, series, breaking news, features, photojournalism, commentary, illustration, and front page design. This is...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login